ACTU
Actuate Therapeutics (ACTU)
$98
About Actuate Therapeutics (ACTU)
Actuate Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing therapeutics which target cancers and neurodegenerative diseases. It offers treatment for cancer and inflammatory diseases. It focuses on developing elraglusib. The company was founded by Andrew P. Mazar on January 16, 2015 and is headquartered in Fort Worth, TX.
Details
Daily high
$7.05
Daily low
$6.83
Price at open
$7.03
52 Week High
$11.99
52 Week Low
$5.47
Market cap
162.2M
Dividend yield
0.00%
Volume
447,636
Avg. volume
95,894
P/E ratio
-5.77
Actuate Therapeutics News
Details
Daily high
$7.05
Daily low
$6.83
Price at open
$7.03
52 Week High
$11.99
52 Week Low
$5.47
Market cap
162.2M
Dividend yield
0.00%
Volume
447,636
Avg. volume
95,894
P/E ratio
-5.77